Multiply Labs

We are very excited to unveil our cell therapy manufacturing robots! This is the first end-to-end system that is compatible with the leading GMP instruments, so your process can be automated without changes. Thank you @jasonjoyride for featuring us in S³, we had a blast!

@AstraZeneca We're also on the Robot Report: therobotreport.com/multiply-labs-…

January has been a strong month for @multiplylabs! Today we’re announcing a new collaboration with @AstraZeneca to evaluate the application of 𝗚𝗠𝗣-𝗿𝗲𝗮𝗱𝘆 𝗿𝗼𝗯𝗼𝘁𝗶𝗰 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝘁𝗼 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹-𝘀𝗰𝗮𝗹𝗲 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴!

@AstraZeneca Find the press release here: businesswire.com/news/home/2026…

What makes this especially exciting is the fit: combining some of the world’s best scientific and clinical expertise at AstraZeneca with our robotic platform as we evaluate what the next generation of high-throughput, GMP-ready cell therapy manufacturing can look like.

Which one is 𝗿𝗲𝗮𝗹, and which one is 𝘀𝗶𝗺!? More importantly, 𝙬𝙝𝙮 𝙖𝙧𝙚 𝙬𝙚 𝙙𝙤𝙞𝙣𝙜 𝙩𝙝𝙞𝙨? 𝗧𝗵𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗧𝘄𝗶𝗻: Together with @nvidia, we’re using Isaac Sim to build 𝗵𝗶𝗴𝗵-𝗳𝗶𝗱𝗲𝗹𝗶𝘁𝘆 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝘁𝘄𝗶𝗻𝘀 of our robotic clusters so our engineers can: - 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗲 sequences and safety logic 𝘣𝘦𝘧𝘰𝘳𝘦 𝘵𝘩𝘦𝘺 𝘵𝘰𝘶𝘤𝘩 𝘩𝘢𝘳𝘥𝘸𝘢𝘳𝘦. - Develop features 𝗳𝗮𝘀𝘁𝗲𝗿, stress-testing edge cases we’d 𝘯𝘦𝘷𝘦𝘳 𝘳𝘶𝘯 𝘰𝘯 𝘢 𝘭𝘪𝘷𝘦 𝘴𝘺𝘴𝘵𝘦𝘮. - 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗮𝗰𝗰𝗲𝘀𝘀 so any engineer can test 𝘸𝘪𝘵𝘩𝘰𝘶𝘵 𝘣𝘰𝘰𝘬𝘪𝘯𝘨 𝘴𝘤𝘢𝘳𝘤𝘦 𝘤𝘭𝘶𝘴𝘵𝘦𝘳 𝘵𝘪𝘮𝘦. 𝗧𝗵𝗲 𝗪𝗵𝘆: In cell therapy manufacturing, 𝙚𝙫𝙚𝙧𝙮 𝙢𝙞𝙣𝙪𝙩𝙚 𝙤𝙣 𝙖 𝙥𝙧𝙤𝙙𝙪𝙘𝙩𝙞𝙤𝙣 𝙘𝙡𝙪𝙨𝙩𝙚𝙧 𝙞𝙨 𝙥𝙧𝙚𝙘𝙞𝙤𝙪𝙨. Our goal at @multiplylabs is simple: keep our production systems focused on 𝘮𝘢𝘬𝘪𝘯𝘨 𝘵𝘩𝘦𝘳𝘢𝘱𝘪𝘦𝘴 𝘧𝘰𝘳 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴, while we iterate and validate processes 𝘀𝗮𝗳𝗲𝗹𝘆 𝗶𝗻 𝘀𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻! Huge thanks to our collaborators @nvidia Healthcare and support from @NVIDIARobotics, as well as the Isaac Sim Team for empowering us with their next-generation software-in-the-loop simulation technology! Our mission is to build the 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗯𝗲𝘀𝘁 𝗿𝗼𝗯𝗼𝘁𝘀 and use them to make 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘄𝗶𝗱𝗲𝗹𝘆 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲. If you love cutting edge robotics, or love the use of robotics for good, please leave a comment below - we’re always looking for talented builders! #robotics #biomanufacturing #simulation #digitaltwin #celltherapy #nvidia

Multiply Labs is transforming cell & gene therapy with UR cobots 🚀 ✅ 74% cost reduction ✅ 100x more patient doses per sq. ft. ✅ Higher sterility + quality UR’s precision + cleanroom compatibility made it possible. Read the case study 👉 urrobots.com/iUk

The year is 2025 - our interns use VR headsets to teleoperate humanoid robots for pharma manufacturing, where sterility is essential for life-saving therapies. Give ambitious people projects at the edge of possibility, and they do extraordinary things! #Robotics #VR #Pharma

Humanoid robots have always captured the imagination. But what happens when we move beyond science fiction—and into the cleanroom? In Episode 2 of Cell Mates, we’re joined by Tony Yang, Director of North American Markets at Unitree Robotics, to explore the real-world potential of humanoids in pharmaceutical manufacturing. 🎧 Listen now: 🎥 YouTube: youtube.com/watch?v=HfNoHa… → Spotify: open.spotify.com/episode/5yzS6i… → Apple Podcasts: podcasts.apple.com/se/podcast/cel… #humanoids #biomanufacturing #robotics #automation #cellmates

At Multiply Labs, we’re building the robotic future of biomanufacturing—but behind every robot action is a team of brilliant individuals making it all possible. Nadia, our head of Robotics Software, together with Varun, Nicole, and Justin are just a few of our robotic software engineers who have been instrumental in bringing our latest robotic cluster to life. We’re proud to show off the people who bring heart, creativity, and serious technical firepower to our mission. Here’s to the humans behind the robots! #biomanufacturing #robotics #advancedtherapies #engineers

At Multiply Labs, we've redefined biomanufacturing from first principles—standardizing fundamental "unit operations" for scalable, seamless automation. Check out our unit operations in action, and reach out at info@multiplylabs.com to learn more! #robotics #biomanufacturing

Happy to announce that we have formally moved into our new HQ in the heart of the vibrant San Francisco Dogpatch District! Our expanded space marks an exciting chapter as we scale up our robotic vision for biomanufacturing, enabling widespread patient access to therapies that can transform - and even save - lives. There's nothing like experiencing our robots up close. If you’re in the area, reach out! We'd be excited to show you the future we're building 🦾 ! #biomanufacturing #automation #newoffice

As we scaled the throughput of our robotic systems at @multiplylabs, we realized that wherever there are humans performing repetitive tasks, that always eventually becomes the bottleneck. Watch our engineering journey below in our first ever "Lab Notes" style video!

In high-performance computing, even the fastest CPUs sit idle waiting on disk or network I/O—wasting precious cycles and capping performance. The same holds true in robotic biomanufacturing: continuous operation of a high-throughput cluster demands seamless and rapid input and output of materials. That's why we built the IOM (Input Output Module): built around a configurable deck plate system you can swap in minutes to keep the cluster humming. One deck plate loads up to: ➡️ 4 Robotic G-Rex Cartridges ➡️ 6 Reagent Bags ➡️ 48 Robotic Syringes ➡️ 48 Robotic Vials ➡️ 18 VIA1 Cell Counting Cassettes ➡️ 240 Disinfection Caps No manual hand-offs. No downtime. Zero wasted cycles—just around-the-clock operation at peak performance. 🎥 Hit play on the 40-second demo to see the IOM in action! P.S. Stick around to the end of the video for a cameo from @UnitreeRobotics! #biomanufacturing #robotics #automation

We're proud to share that Multiply Labs has been featured in the latest issue of Cell & Gene Therapy Insights! Read the article: insights.bio/cell-and-gene-… Our Co-Founder & CEO, @FredParietti, discussed the transformative impact of automation in scaling advanced cell and gene therapy manufacturing. Key Insights: ➡️Efficiency Via Parallelism: Our robotic systems can parallelize up to 18 patient products per incubator, with up to 10 incubators in one cluster. ➡️Modular Flexibility: Our modular cluster layout allows for seamless integration into existing processes, enabling scalable and adaptable manufacturing with standardized bioprocessing modules. ➡️AI-Driven Precision: Through imitation learning, our robots can autonomously learn from existing processes to perform complex tasks with human-like accuracy, enhancing consistency and throughput. #automation #biomanufacturing #cellandgenetherapy #robotics

We strapped a Go-Pro onto our new robots to show you what it looks like from their perspective - clean, repeatable, and automated! Here you see a bag get loaded into an industry-standard incubator, completely autonomously. The future of biomanufacturing is robotic! #robotics #biomanufacturing

Can robots match trained human precision in cell therapy manufacturing? According to our latest study: yes! This is the first side-by-side comparison of robotic vs. human execution of key bioprocessing steps 📖 Read: biorxiv.org/content/10.110… 🎥 Watch: Below to see it in action!